Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry.

Edwin M. Spithoven,Anneke Kramer,Esther Meijer,Bjarne Orskov,Christoph Wanner,José María Abad,Nuria Aresté,Ramón Alonso de la Torre,Fergus Caskey,Cécile Couchoud,Patrik Finne,James G. Heaf,Andries J. Hoitsma,Johan De Meester,Julio Pascual,Maurizio Postorino,Pietro Ravani,Oscar Zurriaga,Kitty J. Jager,Ron T. Gansevoort

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry.

2014

Autosomal dominant polycystic kidney disease (ADPKD) is the fourth most common renal disease requiring renal replacement therapy (RRT). Still, there are few epidemiological data on the prevalence of, and survival on RRT for ADPKD.

Keywords:

Intensive care medicine
Renal replacement therapy
Disease
Diabetes mellitus
Transplantation
Hemodialysis
Epidemiology
Peritoneal dialysis
Autosomal dominant polycystic kidney disease
Medicine
Survival analysis
Hazard ratio
Population
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

130

Citations